Publications
Selected Publications
Development of molecules for efficient genome transgenesis
Chromatin and epigenetic basis of stemness
Vaccine development
© Dr. Hesam Dehghani 2022
•
Dehdilani N, Yousefi Taemeh S, Goshayeshi L, Dehghani H. Genetically engineered birds; pre-CRISPR and
CRISPR era†. Biol Reprod. 2022 Jan 13;106(1):24-46.
•
Soleymani S, Tavassoli A, Hashemi Tabar G, Kalidari GA, Dehghani H. Design, development, and evaluation of
the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E.
coli (APEC) O78:K80 serotype. Vet Res. 2020 Dec 9;51(1):144. doi: 10.1186/s13567-020-00867-w.
•
Tavassoli A, Soleymani S, Haghparast A, Hashemi Tabar G, Bassami MR, Dehghani H. Reverse Genetics
Assembly of Newcastle Disease Virus Genome Template Using Asis-Sal-Pac BioBrick Strategy. Biol Proced
Online. 2020;22:9. doi: 10.1186/s12575-020-00119-3. eCollection 2020.
•
Tabatabaeizadeh SE, Bassami MR, Haghparast A, Dehghani H. Employing XIAP to enhance the duration of
antigen expression and immunity against an avian influenza H5 DNA vaccine. Immunol Invest.
2015;44(3):199-215. doi: 10.3109/08820139.2014.988718.
•
Rezazade Bazaz M, Ghahramani Seno MM, Dehghani H. Transposase-CRISPR mediated targeted integration
(TransCRISTI) in the human genome. Sci Rep. 2022 Mar 1;12(1):3390.
•
Goshayeshi L, Yousefi Taemeh S, Dehdilani N, Nasiri M, Ghahramani Seno MM, Dehghani H. CRISPR/dCas9-
mediated transposition with specificity and efficiency of site-directed genomic insertions. FASEB J. 2021
Feb;35(2):e21359. doi: 10.1096/fj.202001830RR.
•
Zare K, Shademan M, Ghahramani Seno MM, Dehghani H. CRISPR/Cas9 Knockout Strategies to Ablate CCAT1
lncRNA Gene in Cancer Cells. Biol Proced Online. 2018;20:21. doi: 10.1186/s12575-018-0086-5. eCollection
2018.
•
Dehghani H. Regulation of Chromatin Organization in Cell Stemness: The Emerging Role of Long Non-coding
RNAs. Stem Cell Rev Rep. 2021
•
Shademan M, Zare K, Zahedi M, Mosannen Mozaffari H, Bagheri Hosseini H, Ghaffarzadegan K, Goshayeshi L,
Dehghani H. Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas
and adenocarcinomas. Cancer Cell Int. 2020;20:426. doi: 10.1186/s12935-020-01511-5. eCollection 2020.
•
Soltanian S, Dehghani H. BORIS: a key regulator of cancer stemness. Cancer Cell Int. 2018;18:154. doi:
10.1186/s12935-018-0650-8. eCollection 2018. Review.
•
Es-Haghi M, Soltanian S, Dehghani H. Perspective: Cooperation of Nanog, NF-κΒ, and CXCR4 in a regulatory
network for directed migration of cancer stem cells. Tumour Biol. 2016 Feb;37(2):1559-65. doi:
10.1007/s13277-015-4690-6.
•
Fussner E, Ahmed K, Dehghani H, Strauss M, Bazett-Jones DP. Changes in chromatin fiber density as a marker
for pluripotency. Cold Spring Harb Symp Quant Biol. 2010;75:245-9. doi: 10.1101/sqb.2010.75.012.
•
Ahmed K, Dehghani H, Rugg-Gunn P, Fussner E, Rossant J, Bazett-Jones DP. Global chromatin architecture
reflects pluripotency and lineage commitment in the early mouse embryo. PLoS One. 2010 May
7;5(5):e10531. doi: 10.1371/journal.pone.0010531.
•
Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, Bazett-Jones DP, Le Grice S, McKay RD,
Buetow KH, Gingeras TR, Misteli T, Meshorer E. Global transcription in pluripotent embryonic stem cells. Cell
Stem Cell. 2008 May 8;2(5):437-47. doi: 10.1016/j.stem.2008.03.021.
•
Dehghani H, Dellaire G, Bazett-Jones DP. Organization of chromatin in the interphase mammalian cell.
Micron. 2005;36(2):95-108. doi: 10.1016/j.micron.2004.10.003.